The leading market experts have placed a mean price target of $27.26 on Boston Scientific Corporation (NYSE:BSX) stock. This price level, which is estimated to be attained in one-year, indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.29 a share for the upcoming quarter and $1.10 for the current fiscal.
The technical analysis of Boston Scientific Corporation C plainly substantiates that the 50-day moving average of Boston Scientific Corporation C is $23.99, and stock is trading $0.27 points away or +1.15% from its 50-day moving average of $23.99. Further it is trading $2.81 or +13.10% away its 200-day moving average of $21.45. Boston Scientific Corporation (NYSE:BSX) 52-week high is $24.79 and the 52-week low is $15.67.
This explains if the stock moves $-0.53, it will post a 52-week high. In event of +54.82% decline, a 52-week low will be hit.
Taking the valuation aspect to emphasize the valuation of Boston Scientific Corporation C, shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Boston Scientific Corporation (NYSE:BSX) ratio came in at N/A.
The stock last ended the trading session at $24.26 and registered a market cap of $33.01B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Boston Scientific Corporation (NYSE:BSX) PEG ratio is at 1.69.
1 Chart Pattern Every Investor Should Know